
Jan 22 (Reuters) -
MENDRA LAUNCHES WITH $82 MILLION SERIES A TO ACQUIRE, DEVELOP, AND COMMERCIALIZE THERAPEUTICS FOR HIGH UNMET NEED RARE DISEASES
MENDRA: ROUND WAS CO-LED BY ORBIMED, 8VC, AND 5AM VENTURES WITH PARTICIPATION FROM LUX CAPITAL AND WING VC
Further company coverage: [ ]